
|Videos|October 11, 2016
Evidence and Outcomes in Atopic Dermatitis
Advertisement
Panelists Peter L. Salgo, MD; Jeffrey D. Dunn, PharmD, MBA; Ed Pezalla, MD, MPH; Jonathan Silverberg, MD, PhD, MPH; and Cheryl Allen, BS Pharm, MBA, provide insight on the evidence and outcomes in atopic dermatitis and how they impact coverage.
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Updates in Treatment of Unresectable Hepatocellular Carcinoma
2
FDA Approves Rucaparib for the Treatment of Adults With mCRPC
3
Infliximab and Adalimumab Biosimilars Maintain Comparable Safety, Efficacy, Immunogenicity in IBD
4
Notable Updates in Medication Therapy Management in 2025
5











































































































































































































